Tag: WHO

  • Vapers’ Alliance Challenges WHO Ahead of COP11

    Vapers’ Alliance Challenges WHO Ahead of COP11

    As the World Health Organization’s COP11 tobacco-control conference approaches, the World Vapers’ Alliance (WVA) is calling for consumers to be heard, projecting messages onto the venue demanding inclusion in policy discussions. WVA Director Michael Landl criticized the event as “an echo chamber stuck in outdated, anti-science thinking.”

    “Harm reduction isn’t a marketing ploy, it’s a public health necessity supported by hard data,” Landl said. “Consumers’ lives matter more than ideology or the views of wealthy WHO donors like Michael Bloomberg. It’s time consumers got a real seat at the table.”

    The group warned that WHO proposals to ban flavored vaping, cap nicotine levels, and raise taxes ignore scientific evidence that vaping and nicotine pouches are less harmful alternatives for smokers. WVA’s Liza Katsiashvili cautioned that bans and high taxes would only drive consumers to cigarettes or black markets, urging delegates to “listen to the facts, not ideology.” The WVA’s “Voices Unheard – Consumers Matter” campaign calls for governments to prioritize evidence-based regulation and give consumers a voice in global tobacco policy.

  • War on Tobacco or Assault on National Power?: Editorial

    War on Tobacco or Assault on National Power?: Editorial

    “In Brussels, they talk of ‘regulatory simplification,’ yet in international forums, they negotiate new layers of global bureaucracy, from tobacco to digital health and climate governance,” wrote analyst Javier Villamor in an article for The European Conservative. “But beyond the sanitary or environmental narrative, the plan represents a new attempt by Brussels to concentrate fiscal and regulatory powers at the expense of the Member States.”

    Villamor argues that as the European Union sidles up to the World Health Organization with its upcoming tobacco control conference (COP11), the actual purpose is to transfer regulatory power from national governments to international agencies without democratic oversight, as Brussels plans to automatically incorporate WHO-aligned measures into EU law.

    “What appears to be a technical step is, in reality, the transfer of Europe’s regulatory sovereignty to an international agency with no democratic legitimacy,” Villamor wrote. “Brussels not only intends to sign commitments on behalf of the Member States but also to incorporate them automatically into EU law through the forthcoming revision of the Tobacco Products Directive.

    “In practice, this would mean that decisions taken in Geneva offices could become binding bans in Madrid, Rome, or Warsaw—without parliamentary debate or national impact assessment.”

    As Brussels considers restrictions, bans, and taxes on virtually every product containing tobacco or nicotine, framing it all as a public health and environmental initiative, the plan includes fiscal measures under the Tobacco Excise Directive (TED) and Tobacco Excise Duty on Raw Tobacco (TEDOR), enabling the EU to directly collect up to 15% of national excise revenues and impose duty hikes of up to 900% on certain products. Observers, Villamor says, warn that such moves centralize authority, undermine the principle of subsidiarity, and risk harming over 80,000 European tobacco producers and small retailers, while benefiting third countries like Morocco and China.

    “The so-called ‘anti-tobacco crusade’ becomes a vehicle for recentralizing authority and financing the EU’s bureaucratic machinery under the guise of public health,” Villamor wrote. “The mechanism is well known: Brussels funds these organizations, they in turn demand that EU law be aligned with the WHO, and the Commission presents their demands as a ‘civil society consensus.’ A closed feedback loop of influence, where citizens pay to lose sovereignty.

    “Paradoxically, the countries with the best results in reducing smoking, such as Sweden, which has cut its rate to 5% thanks to regulated alternatives like snus and nicotine pouches, would be penalized for adopting effective national policies outside the WHO’s dogma.”

  • ITGA Demands Inclusion Ahead of WHO COP11

    ITGA Demands Inclusion Ahead of WHO COP11

    On World Tobacco Growers’ Day, global tobacco farmers raised concerns over their continued exclusion from international policymaking, calling for transparency and inclusion ahead of next month’s WHO Framework Convention on Tobacco Control (FCTC) Conference of the Parties (COP11) in Geneva. International Tobacco Growers’ Association president José Javier Aranda sent a letter saying the FCTC process has become increasingly opaque, with decisions made behind closed doors and little agricultural representation—fewer than 5% of delegates have expertise in farming. He warned that measures discussed at COP11 could impact millions of livelihoods across tobacco-producing nations.

    “We understand the concerns about the negative impact of tobacco consumption, and we support policies that are genuinely aimed at reducing harm,” Aranda said. “But what we cannot understand is why tobacco growers and their representatives are given such a fundamentally different treatment compared to other sectors.

    “As representatives of tobacco growers, we cannot remain silent. We raise our voice today to condemn this misconduct of the WHO FCTC Secretariat. Our governments must stand with us. I have already sent a letter to the WHO and the WHO FCTC, calling for transparency and inclusion. We expect to be heard.”

  • Nigeria Health Advocates Push for 50% Tobacco Tax

    Nigeria Health Advocates Push for 50% Tobacco Tax

    Health stakeholders and tobacco control advocates at the Gatefield Health Summit 2025 urged the Nigerian government to raise tobacco taxes to 50% of the retail price, citing the measure as a key tool to reduce smoking, prevent related illnesses, and protect public health. Experts highlighted that Nigeria’s current tax level of about 25% falls well below the World Health Organization’s recommended 75% of retail price.

    Michael Olaniyan, Country Representative for the Campaign for Tobacco-Free Kids, claimed that higher taxes are effective in deterring youth smoking, while Chibuike Nwokorem of the Nigeria Tobacco Control Alliance criticized tobacco companies for exploiting weak enforcement mechanisms and influencing policy decisions through industry associations.

  • WHO Secretariat Accuses Tobacco Industry of Interference

    WHO Secretariat Accuses Tobacco Industry of Interference

    The Secretariat of the WHO Framework Convention on Tobacco Control (FCTC) accused the tobacco industry of ramping up efforts to interfere with international tobacco control policymaking in advance of the Conference of the Parties (COP11) beginning November 17 in Geneva, according to the Albanian Daily News (ADN). Andrew Black, acting head of the WHO FCTC Secretariat, condemned what he described as deliberate attempts to weaken global health measures.

    “With strategies varying from lobbying to outright attempts to manipulate delegations, the tobacco industry’s tactics are a cause for serious concern,” Black was quoted by the ADN. “This is not just lobbying; it is a deliberate strategy to try to derail consensus and weaken measures to further the treaty’s implementation. Tobacco industry interference is one of the biggest constraints and barriers to the implementation of the Convention. The Secretariat strongly urges Parties, civil society, and other stakeholders working to support tobacco control to remain vigilant against the industry’s tactics and misinformation.”

    The COP11 session will bring together representatives from across the globe to discuss new policies to curb nicotine addiction, protect human health, and address environmental harms linked to tobacco.

  • UK Set to Miss 2030 Smoke-Free Target, New Analysis Finds

    UK Set to Miss 2030 Smoke-Free Target, New Analysis Finds

    A new analysis by Haypp, in collaboration with Swedish economist David Sundén, shows that the UK is unlikely to achieve its goal of being smoke-free by 2030 if current trends continue. Based on smoking rate declines across the UK and EU, England is projected to reach smoke-free status in 2032, Wales in 2033, Scotland in 2034, and Northern Ireland not until 2037. The study defines smoke-free as having less than 5% of the population smoking daily, in line with the World Health Organization criteria.

    The report highlights Sweden as a global leader, set to become smoke-free on October 25, 2025, driven by high cigarette taxes and widespread access to alternatives like snus and nicotine pouches. In comparison, the UK’s overall daily smoking rate remains at 11.9%, with rates among young adults (18–24) at 9.8%. Sweden’s young-adult smoking rate is 2.3%.

    Sundén notes that while alternatives such as vapes have helped reduce smoking, the rate of decline is slowing and some regions have even seen slight increases over the past year.

    The analysis also points to the potential public health impact if the UK adopted Sweden’s harm reduction strategies. Markus Lindblad, Haypp’s Director of External Affairs, emphasized that the UK has an opportunity to follow Sweden’s approach, using alternative nicotine products to accelerate the transition away from combustible tobacco as Parliament considers the Tobacco and Vapes Bill.

  • TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    The Taxpayers Protection Alliance (TPA) released a new policy brief today (October 20), “FCTC: The Wrong Lessons Learned,” by Roger Bate, a fellow at the International Center for Law and Economics, criticizing the World Health Organization’s Framework Convention on Tobacco Control (FCTC) for drifting from its original mission of evidence-based policy. The paper argues that the treaty’s decision-making process has become obscured, ideological, and resistant to scientific debate—particularly around harm reduction products such as e-cigarettes and oral nicotine.

    “The FCTC has evolved into a closed process—hostile to scientific dissent, opaque in its deliberations, and resistant to consumer-driven innovation in tobacco harm reduction (THR),” the paper begins. “This paper argues that the FCTC has become a cautionary model for global public-health governance. Unless checked, this model risks entrenching an authoritarian and anti-scientific impulse across public health. The THR community must lead the counter-narrative—to reform tobacco control and safeguard the integrity of evidence-based policymaking.”

    Bate contends that the FCTC’s approach “demonizes safer alternatives despite real-world success,” preventing adult smokers from accessing less harmful products that could help them quit. He warns that the treaty’s governance flaws mirror broader problems in global health governance, including pandemic response. “A treaty built to reduce smoking deaths should evaluate tools by outcomes, not ideology,” he said.

    The brief calls for reforms, including open sessions at FCTC Conferences of the Parties (COPs), equal conflict-of-interest scrutiny, independent comparisons of cessation tools, proportionate youth protections, and fiscal accountability. TPA fellow Martin Cullip urged the WHO to “reassess the evidence on reduced-risk nicotine products” and improve transparency, warning that the FCTC’s current direction “has become an obstacle to global public health progress.”

  • WHO Facing Crises of Relevance, Former Director Says

    WHO Facing Crises of Relevance, Former Director Says

    Dr. Tikki Pang, a professor and former Director of Research Policy and Cooperation at the World Health Organization (WHO), delivered a compelling keynote at the Global Tobacco and Nicotine Forum (GTNF) in Brussels, urging the global public health community to “find a detour” around entrenched opposition to tobacco harm reduction (THR). Drawing a vivid analogy, Pang said the WHO’s position acts like a “landslide blocking the road” to progress, creating ripple effects that influence policy, weaken public trust, and stigmatize innovation. Attempts to change this stance, he said, have proven “frustrating and futile.”

    “‘Tobacco control’ has become the complete elimination of tobacco in society,” Pang said. “It’s become pretty much ideological at this point. It has become evidence-selective, perhaps evidence-blind.

    “We need to overcome this perception that the industry is the cause of the problem and not part of the solution.’

    Pang described the journey toward a THR-friendly world as “a long road with many obstacles,” and warned that the EU’s recent alignment with anti-THR policies could have “global repercussions.” Instead, he called for a “circuit breaker” — independent, multi-stakeholder platforms that operate outside the WHO’s Conference of the Parties (COP) framework. These coalitions should unite industry, consumers, investors, media, and advocates to advance harm reduction directly, he said.

    Pang emphasized the crucial role of media and advocacy in countering misinformation, noting that journalists can either “spread misconceptions or become powerful allies.” He also suggested situating THR within the broader context of non-communicable disease (NCD) prevention.

    Reflecting on his 13 years at the WHO, Pang acknowledged its achievements in supporting underserved populations but said the organization now faces “a crisis of relevance and confidence.” He concluded that while the WHO’s mission explicitly includes improving global health — including for smokers seeking better alternatives — progress will depend on using science-driven innovation and rational policy to achieve that goal.

    “Science has given us the tools to reduce harm from tobacco,” Pang said. “Reason dictates that we should use them.”

  • BAT’s Wheaton Calls for Policymakers to Embrace Harm Reduction at GTNF Opening

    BAT’s Wheaton Calls for Policymakers to Embrace Harm Reduction at GTNF Opening

    Brussels, October 6, 2025 — Kingsley Wheaton, Chief Corporate Officer of BAT, opened the Global Tobacco and Nicotine Forum (GTNF) with a call for policymakers to embrace harm reduction and real-world evidence as the basis for future regulation.

    “Right now, we stand at a crossroads,” Wheaton said. “One where the choices we make — as individuals, as companies, and as an industry — will shape the future of public health, policy, and perception.”

    Speaking under the GTNF’s theme, “Real World Evidence: The Race to Reduce Harm,” Wheaton argued that Sweden’s near smoke-free status demonstrates the effectiveness of tobacco harm reduction. He credited awareness campaigns, consumer access to smokeless products, and progressive regulation for driving smoking rates to among Europe’s lowest.

    “Sweden is on the verge of achieving something extraordinary: a smoking rate of just 5.3%—less than a quarter of the EU average,” he said. “This isn’t just a number. It’s a public health milestone. And it’s a powerful validation of a strategy that many dismissed: harm reduction.

    “Despite decades of global anti-smoking campaigns, 1 billion people still smoke. At BAT, we believe quitting is the best choice any smoker can make. But for those who won’t quit, offering scientifically substantiated, reduced-risk alternatives is essential. Sweden proves this approach works.”

    In his remarks, Wheaton touted the success of BAT’s Omni program, the company’s global platform and manifesto for tobacco harm reduction launched in 2024. He said Omni is both a movement and a communications framework through which BAT promotes its vision of a “Smokeless World,” aiming to make smokeless products mainstream and push for regulatory environments that support harm reduction.

    “With Omni, we’re launching a platform for science, dialogue, and collaboration to accelerate progress toward a smokeless world,” Wheaton said. “This transformation took belief—belief that we could be part of the solution. And today, I’m proud to say: we were right to believe in it.

    Wheaton also criticized prohibitionist policies, pointing to Australia’s illicit market as evidence of unintended consequences when safer alternatives are restricted. He urged EU policymakers to adopt proportionate, risk-based regulation that recognizes harm reduction as part of tobacco control.

    “How can policymakers not see what’s right in front of their eyes?” Wheaton said. “When safer alternatives are blocked, the void is filled by danger, not progress. It’s time to rethink, recalibrate, and reclaim the narrative. So perhaps it’s time to ask: What if the most effective way to end smoking isn’t to fight nicotine, but to reimagine it? What if the companies that once sold cigarettes can now lead the charge to make them obsolete?

    “The WHO continues to ignore and sideline harm reduction, clinging to outdated dogma while real-world evidence piles up. This is not just intransigence, it’s negligence. It’s time for policymakers to stop pretending this evidence doesn’t exist. Seventy percent of policy experts still believe nicotine is the primary cause of smoking-related diseases, like cancer. That’s not just inaccurate, it’s dangerous. If we’re serious about closing the Tobacco Harm Reduction deficit, we must engage directly with regulators, health authorities, and policy experts to ensure that safer alternatives are not just available, but understood, accepted, and encouraged.”

    The GTNF is the world’s leading annual conference discussing the future of the tobacco and nicotine industries. It is the global exchange for views and ideas between public health experts, government representatives, the industry, and investors.

  • What Role Does the FCTC Play in Today’s Regulatory Environment?

    What Role Does the FCTC Play in Today’s Regulatory Environment?

    At the Global Tobacco and Nicotine Forum (GTNF) in Brussels, an expert panel explored the growing disconnect between the World Health Organization’s Framework Convention on Tobacco Control (FCTC) and real-world tobacco harm reduction (THR) progress. The session featured Dr. Derek Yach, global health advocate and former WHO executive; Peter Beckett, Co-Founder of Clearing the Air; Dr. Tikki Pang, a professor and former WHO Director of Research Policy and Cooperation; and Dr. Christopher Snowdon, Head of Lifestyle Economics at the Institute of Economic Affairs.

    Yach opened the discussion by criticizing the gap between FCTC policymaking and on-the-ground data. He noted that smoking rates are falling faster in countries embracing harm reduction — such as the U.S., U.K., Japan, South Korea, and New Zealand — than under traditional tobacco control strategies. “If it can happen in Pakistan, it can happen in all of Southeast Asia,” he said. “And if it happens in Southeast Asia, we could be seeing oral cancer in the rearview mirror.” Yach emphasized the need for collaborative public–private partnerships to ensure product safety and credibility, while urging policymakers to move beyond what he called the “distraction” of youth-related arguments that ignore the millions of adult smokers seeking alternatives.

    “It’s not that youth use isn’t important, but putting all the attention on kids doesn’t help for 50 years,” he said. “What about their parents? We could be adding years to their lives right now. [Anti-THR people] just use the youth as a way to divide the argument. We need to shift to the data and take the kid issue off the table.”

    Beckett took a blunt tone, arguing that the FCTC framework is obsolete, exclusive, and lacking transparency. He said the WHO’s current approach alienates the public and damages its credibility, calling the situation “chaotic,” which makes it easier for harm-reduction advocates to push back on. Beckett urged reform-minded countries — especially WHO funders — to “recognize the world as it is” and resist “bullying by overpaid foundations with an agenda,” and accused prohibitionist groups of crossing the line.

    “Ten years ago, they were disingenuous; now they’re straight-up lying,” he said. “I keep hearing the same damn thing. ‘We need to engage with science, we need to be nice to the other side.’ I’m calling bullshit on that. It doesn’t work. There is no amount of science that will do the job. If there was, they’d let me in the bloody room when they have these conversations. We have to recognize this and say enough, and call for a tearing down of the framework in its entirety, because it’s not salvageable.”

    Pang reiterated that many developing countries adopt WHO guidance without generating or analyzing their own data. “They take the easy way out,” he said, “because they lack the capacity to build evidence locally.” Pang pointed to emerging “pockets of positive thinking” among countries that are now re-evaluating WHO recommendations and embracing THR. He called for greater industry unity — across state-owned, multinational, and startup sectors — and stronger alignment with consumer voices. “Consumers are also voters,” he reminded the audience, “and together they can influence policy.”

    Snowdon warned of troubling developments within the WHO, citing “endgame” proposals that reject harm reduction as an industry “con.” He described this as a “quasi-religious mission to destroy all tobacco,” resistant to evidence and reason. Snowdon noted that while grassroots THR advocacy exists, it ironically remains underfunded and overshadowed by well-resourced opposition.

    “We are greatly out-financed. The industry can contribute, but then we get ostracized,” he said. “We have a genuine grassroots movement, but these people have lives to live. They can’t be doing it all the time. Meanwhile, the other side has unlimited resources. The media could be helpful, but they don’t want to risk it.”

    Across the panel, a consensus emerged: the WHO’s FCTC framework risks irrelevance unless it adapts to include harm reduction. Participants agreed that the future of global health policy must be driven by data, innovation, and collaboration rather than ideology.

    The GTNF is the world’s leading annual conference discussing the future of the tobacco and nicotine industries. It is the global exchange for views and ideas between public health experts, government representatives, the industry, and investors.